Skip to main content
OpenTrials

Clinical trial condition

Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

131 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Gastroesophageal Junction Adenocarcinoma trial results

Recruiting

HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)

NCT04447352

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Uniklinik RWTH Aachen, AöR, Medizinische Klinik III, Studienzentrum Viszeralmedizin Aachen, Germany
  • Universitätsklinikum, Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie Dresden, Germany
  • Institute of Clinical Cancer Research (IKF), UCT - University Cancer Center, Frankfurt, Germany Frankfurt, Germany
  • Universitätsklinikum Halle (Saale), Universitätsklinik und Poliklinik für Viszerale, Gefäß- und Endokrine Chirurgie Halle, Germany
View all 15 locations
View Trial Details
Recruiting

DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy

NCT06221748

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Recruiting

Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.

NCT06155383

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Yunnan Cancer Hospital Kunming, Fujian, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
View Trial Details

Related conditions